APO RESEARCH · REPORT
Estriol
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
Product & engineering
Understand the product.
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
Selected research
Industry Research
Estriol Industry Research Report 2026
Market perspective
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
The leading producers in the sector are Jiangxi Yuneng Pharmaceutical, Shanghai Lianlu Industry and Jiangsu Yuanda SYM Pharmaceutical, with revenues of 28.20 percent, 13.44 percent and 21.48 percent respectively in 2019.
Report Scope
Read the full market overview
This report quantifies the global Estriol market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Estriol Market by Company
Jiangxi Yuneng Pharmaceutical
Shanghai Lianlu Industry
Jiangsu Yuanda SYM Pharmaceutical
Estriol Segment by Type
Purity: <99%
Purity: ≥99%
Estriol Segment by Application
Pharmaceutical
Biological Research
Estriol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estriol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Estriol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estriol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Estriol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Estriol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Estriol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity: <99%
- Purity: ≥99%
Applications
- Pharmaceutical
- Biological Research
Companies covered
- Jiangxi Yuneng Pharmaceutical
- Shanghai Lianlu Industry
- Jiangsu Yuanda SYM Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Estriol Market Size (2021-2032)
- 2.2.2 Global Estriol Sales (2021-2032)
- 2.2.3 Global Estriol Market Average Price (2021-2032)
- 2.3 Estriol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity: <99%
- 2.3.3 Purity: ≥99%
- 2.4 Estriol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical
- 2.4.3 Biological Research
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Estriol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Estriol Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Estriol Revenue of Manufacturers (2021-2026)
- 3.4 Global Estriol Average Price by Manufacturers (2021-2026)
- 3.5 Global Estriol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Estriol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Estriol, Product Type & Application
- 3.8 Global Manufacturers of Estriol, Established Date
- 3.9 Global Estriol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Jiangxi Yuneng Pharmaceutical
- 4.1.1 Jiangxi Yuneng Pharmaceutical Company Information
- 4.1.2 Jiangxi Yuneng Pharmaceutical Business Overview
- 4.1.3 Jiangxi Yuneng Pharmaceutical Estriol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Jiangxi Yuneng Pharmaceutical Estriol Product Portfolio
- 4.1.5 Jiangxi Yuneng Pharmaceutical Recent Developments
- 4.2 Shanghai Lianlu Industry
- 4.2.1 Shanghai Lianlu Industry Company Information
- 4.2.2 Shanghai Lianlu Industry Business Overview
- 4.2.3 Shanghai Lianlu Industry Estriol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Lianlu Industry Estriol Product Portfolio
- 4.2.5 Shanghai Lianlu Industry Recent Developments
- 4.3 Jiangsu Yuanda SYM Pharmaceutical
- 4.3.1 Jiangsu Yuanda SYM Pharmaceutical Company Information
- 4.3.2 Jiangsu Yuanda SYM Pharmaceutical Business Overview
- 4.3.3 Jiangsu Yuanda SYM Pharmaceutical Estriol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Yuanda SYM Pharmaceutical Estriol Product Portfolio
- 4.3.5 Jiangsu Yuanda SYM Pharmaceutical Recent Developments
5 Global Estriol Market Scenario by Region
- 5.1 Global Estriol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Estriol Sales by Region: 2021-2032
- 5.2.1 Global Estriol Sales by Region: 2021-2026
- 5.2.2 Global Estriol Sales by Region: 2027-2032
- 5.3 Global Estriol Revenue by Region: 2021-2032
- 5.3.1 Global Estriol Revenue by Region: 2021-2026
- 5.3.2 Global Estriol Revenue by Region: 2027-2032
- 5.4 North America Estriol Market Facts & Figures by Country
- 5.4.1 North America Estriol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Estriol Sales by Country (2021-2032)
- 5.4.3 North America Estriol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Estriol Market Facts & Figures by Country
- 5.5.1 Europe Estriol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Estriol Sales by Country (2021-2032)
- 5.5.3 Europe Estriol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Estriol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Estriol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Estriol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Estriol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Estriol Market Facts & Figures by Country
- 5.7.1 South America Estriol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Estriol Sales by Country (2021-2032)
- 5.7.3 South America Estriol Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Estriol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Estriol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Estriol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Estriol Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Estriol Sales by Type (2021-2032)
- 6.1.1 Global Estriol Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Estriol Sales Market Share by Type (2021-2032)
- 6.2 Global Estriol Revenue by Type (2021-2032)
- 6.2.1 Global Estriol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Estriol Revenue Market Share by Type (2021-2032)
- 6.3 Global Estriol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Estriol Sales by Application (2021-2032)
- 7.1.1 Global Estriol Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Estriol Sales Market Share by Application (2021-2032)
- 7.2 Global Estriol Revenue by Application (2021-2032)
- 7.2.1 Global Estriol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Estriol Revenue Market Share by Application (2021-2032)
- 7.3 Global Estriol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Estriol Value Chain Analysis
- 8.1.1 Estriol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Estriol Production Mode & Process
- 8.2 Estriol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Estriol Distributors
- 8.2.3 Estriol Customers
9 Global Estriol Analyzing Market Dynamics
- 9.1 Estriol Industry Trends
- 9.2 Estriol Industry Drivers
- 9.3 Estriol Industry Opportunities and Challenges
- 9.4 Estriol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst